Neurinnov
Develops implantable neurostimulation devices for people with paralysis, initially targeting hand function in complete tetraplegia
Highlights
- New on EvolcAdded 2026-10-31
About Neurinnov
Neurinnov develops implantable neurostimulation solutions designed to selectively activate targeted muscles through electrical stimulation of nerves. Its initial focus is restoring hand grasping function for people with complete spinal cord injuries.
The company is a spin-off from INRIA and the University of Montpellier, founded in 2018 by David Andreu and David Guiraud. It is headquartered in Montpellier, France, and has an R&D site in Grabels. Its clinical research includes early-stage feasibility studies.
Product: An implantable neurostimulation device and technology platform for selectively activating muscles through nerve stimulation.
Jobs at Neurinnov
Leadership
- David Guiraud · Co-founder and CSOSource: company website
- David Andreu · Co-founder, CTO and General ManagerSource: company website
More health & medtech companies
Newclip Technics
Osteosynthesis implants and instruments for orthopedic surgeons in hospitals and clinicsNew on EvolcNexus/France
Hospital patient-record, operating-theatre and sterilisation software for French hospitals and clinicsNew on EvolcNHC
Home-care services for patients receiving nutrition, diabetes, infusion and Parkinson’s treatments in FranceNew on EvolcNormandy Hadrontherapy
Develops cyclotron-based hadrontherapy systems for clinical treatment and research centresNew on EvolcNovesia
Digital therapeutic app QoLibri for patients with chronic pain, prescribed by doctors in FranceYoung companyNew on EvolcOhmcare
Fall and bed-exit detection and nurse-call integration software for healthcare professionalsYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Complianz
- Elementor
- Google Analytics 4
- Google reCAPTCHA
- WordPress
- jQuery